Aspirin versus placebo on estrogen levels in postmenopausal women: a double-blind randomized controlled clinical trial

• Autori principali: Mohammad Bagher Oghazian (Autore), Nooshin Shirzad (Autore), Mahdi Ahadi (Autore), Shalaleh Eivazi Adli (Autore), Samaneh Mollazadeh (Autore), Mania Radfar (Autore)
• Natura: Libro
• Pubblicazione: BMC, 2022-05-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Background Estrogen is involved in the pathogenesis of breast and gynecological cancers. Regular use of aspirin reduces estrogen levels. The present study aimed to evaluate the effect of aspirin on estrogen levels in postmenopausal women. Methods This double-blind, placebo-controlled parall...